U.S. topical pain relief Market to Reach $3.73 Billion by 2025 at 6.0% CAGR

World News: . []

Portland, OR, Sept. 19, 2019 (GLOBE NEWSWIRE) -- The was accounted for $2.32 billion in 2017 and is projected to reach $3.73 billion by 2025, registering a CAGR of 6.0% from 2018 to 2025. The research offers a detailed analysis of major segments, changing market trends, top pocket investors, drivers & opportunities, and competitive scenarios.

Increase in the rate of geriatric population, rise in prevalence of arthritis, and lesser side effects caused by topical pain relief products as compared to oral medicines are the factors driving the growth of the market. On the other hand, high demand for topical pain relief products by sportsperson supplements the market's growth. However, topical pain relief sometimes causes skin irritation and has unpleasant odor, which restrains the market growth up to a certain extent. Moreover, the development of online pharmacy is estimated to provide lucrative opportunities in the U.S. topical pain relief market.

Based on formulation, the cream segment held the largest share in 2017, contributing nearly two-fifths of the total share. The segment is expected to continue its lead position throughout the estimated period. However, the patch segment would grow at the fastest CAGR of 7.6% during the forecast period.

Based on type, the over-the-counter pain relief segment held the largest major market share in 2017, accounting for more than half of the total market share. This region would continue its leadership position throughout the forecast period. Moreover, the segment would grow at the highest CAGR of 6.6% during the forecast period.

Based on the distribution channel, the pharmacies & drug stores segment held the largest share in 2017, contributing nearly four-fifths of the total share. The segment is expected to continue its position throughout the estimated period. However, the e-commerce segment would grow at the fastest CAGR of 8.7% during the forecast period.

The key players in the U.S. topical pain relief market include Nestle S.A., Johnson & Johnson, Novartis AG, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline Plc., Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Topical BioMedics, Inc and AdvaCare Pharma.

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

More news and information about Allied Market Research

Published By:

Globe Newswire: 15:15 GMT Thursday 19th September 2019

Published: .

Search for other references to "topical" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us